Ongoing
Closed
A REAL-world, retrospective cohort study of the prevention of episodic or chronic migration in patients treated with galcanezumab at headache centers in ITalY: REALITY”.
Thu Dec 16, 2021
Non-invasive gamma stimulation to counteract cognitive and neuropsychiatric symptoms in Mild Cognitive Impairment and Alzheimer's Disease.
Fri 18th Sep 2020. p.m. CEST
Randomized, double-blind, placebo-controlled clinical trial to evaluate the effect and safety of oral semaglutide in subjects with early Alzheimer's disease (EVOKE)
Fri 18th Sep 2020. p.m. CEST
SPEECH MEDICAL REHABILITATION ASSOCIATED WITH VAGAL STIMULATION FOR THE TREATMENT OF DYSPHAGIA AFTER STROKE (LOGIC)
Fri 18th Sep 2020. p.m. CEST
Double-blind randomized interventional study Role of citicoline as supportive therapy in Parkinson's disease (CITIPARK)
Fri 18th Sep 2020. p.m. CEST
Multicenter, randomized, double-blind, parallel-group, placebo-controlled study with an open-label period to evaluate the efficacy and safety of fremanezumab for the prophylactic treatment of migraine in patients with inadequate response to previous preventive treatments
Wed 9 May, 2018
